Esig, Narisa N.

HRN: 23-90-80  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/17/2023
10/23/2023
IV
2.25
Q6
Sepsis; AGE With Severe Dehydration
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Dose  Wrong Dose

Overall appropriateness: No  Wrong Dose

Intervention



Type of Intervention done:

                    

           


Acceptance: